ELRINGKLINGER AG (ZIL2.DE) Fundamental Analysis & Valuation

FRA:ZIL2 • DE0007856023

Current stock price

5.36 EUR
-0.18 (-3.25%)
Last:

This ZIL2.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ZIL2.DE Profitability Analysis

1.1 Basic Checks

  • ZIL2 had negative earnings in the past year.
  • In the past year ZIL2 had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ZIL2 reported negative net income in multiple years.
  • ZIL2 had a positive operating cash flow in each of the past 5 years.
ZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of ZIL2 (-0.33%) is worse than 61.29% of its industry peers.
  • With a Return On Equity value of -1.02%, ZIL2 is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
  • The Return On Invested Capital of ZIL2 (1.12%) is worse than 80.65% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZIL2 is significantly below the industry average of 9.75%.
Industry RankSector Rank
ROA -0.33%
ROE -1.02%
ROIC 1.12%
ROA(3y)-2.07%
ROA(5y)-1.58%
ROE(3y)-6%
ROE(5y)-4.53%
ROIC(3y)3.71%
ROIC(5y)3.71%
ZIL2.DE Yearly ROA, ROE, ROICZIL2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • ZIL2 has a Operating Margin of 1.18%. This is amonst the worse of the industry: ZIL2 underperforms 80.65% of its industry peers.
  • ZIL2's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ZIL2 (22.90%) is comparable to the rest of the industry.
  • ZIL2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.18%
PM (TTM) N/A
GM 22.9%
OM growth 3Y-3.24%
OM growth 5Y6.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y3.54%
ZIL2.DE Yearly Profit, Operating, Gross MarginsZIL2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ZIL2.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZIL2 is destroying value.
  • The number of shares outstanding for ZIL2 remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for ZIL2 remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, ZIL2 has a worse debt to assets ratio.
ZIL2.DE Yearly Shares OutstandingZIL2.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ZIL2.DE Yearly Total Debt VS Total AssetsZIL2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that ZIL2 is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.55, ZIL2 is doing worse than 64.52% of the companies in the same industry.
  • ZIL2 has a debt to FCF ratio of 17.13. This is a negative value and a sign of low solvency as ZIL2 would need 17.13 years to pay back of all of its debts.
  • ZIL2 has a worse Debt to FCF ratio (17.13) than 70.97% of its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that ZIL2 is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ZIL2 (0.62) is better than 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 17.13
Altman-Z 1.55
ROIC/WACC0.18
WACC6.42%
ZIL2.DE Yearly LT Debt VS Equity VS FCFZIL2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that ZIL2 should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.26, ZIL2 perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
  • ZIL2 has a Quick Ratio of 1.26. This is a bad value and indicates that ZIL2 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZIL2 has a worse Quick ratio (0.60) than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.6
ZIL2.DE Yearly Current Assets VS Current LiabilitesZIL2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ZIL2.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 95.54% over the past year.
  • Looking at the last year, ZIL2 shows a decrease in Revenue. The Revenue has decreased by -9.00% in the last year.
  • ZIL2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.08% yearly.
EPS 1Y (TTM)95.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.86%
Revenue 1Y (TTM)-9%
Revenue growth 3Y-3.01%
Revenue growth 5Y2.08%
Sales Q2Q%-8.42%

3.2 Future

  • ZIL2 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 119.82% yearly.
  • Based on estimates for the next years, ZIL2 will show a small growth in Revenue. The Revenue will grow by 4.28% on average per year.
EPS Next Y369.8%
EPS Next 2Y176.58%
EPS Next 3Y119.82%
EPS Next 5YN/A
Revenue Next Year2.36%
Revenue Next 2Y3.53%
Revenue Next 3Y4.5%
Revenue Next 5Y4.28%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZIL2.DE Yearly Revenue VS EstimatesZIL2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
ZIL2.DE Yearly EPS VS EstimatesZIL2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. ZIL2.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • ZIL2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 9.07, the valuation of ZIL2 can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, ZIL2 is valued a bit cheaper than the industry average as 70.97% of the companies are valued more expensively.
  • ZIL2's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.96.
Industry RankSector Rank
PE N/A
Fwd PE 9.07
ZIL2.DE Price Earnings VS Forward Price EarningsZIL2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • ZIL2's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, ZIL2 is valued a bit more expensive than the industry average as 64.52% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 14.46
EV/EBITDA 4.49
ZIL2.DE Per share dataZIL2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ZIL2's earnings are expected to grow with 119.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y176.58%
EPS Next 3Y119.82%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ZIL2.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.48%, ZIL2 has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 3.36, ZIL2 has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, ZIL2 pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.48%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
ZIL2.DE Yearly Dividends per shareZIL2.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.05 0.1

5.3 Sustainability

DP0%
EPS Next 2Y176.58%
EPS Next 3Y119.82%
ZIL2.DE Yearly Income VS Free CF VS DividendZIL2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

More info and screens

Find the best dividend stocksShow peers with best dividend

ZIL2.DE Fundamentals: All Metrics, Ratios and Statistics

ELRINGKLINGER AG

FRA:ZIL2 (4/14/2026, 5:29:56 PM)

5.36

-0.18 (-3.25%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)03-26
Earnings (Next)05-07
Inst Owners3.59%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap339.61M
Revenue(TTM)1.64B
Net Income(TTM)-6.15M
Analysts76.36
Price Target5.04 (-5.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.48%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.44%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.12%
EPS NY rev (3m)6.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)-0.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.07
P/S 0.21
P/FCF 14.46
P/OCF 1.89
P/B 0.56
P/tB 0.69
EV/EBITDA 4.49
EPS(TTM)-0.1
EYN/A
EPS(NY)0.59
Fwd EY11.03%
FCF(TTM)0.37
FCFY6.91%
OCF(TTM)2.83
OCFY52.8%
SpS25.9
BVpS9.55
TBVpS7.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.33%
ROE -1.02%
ROCE 1.61%
ROIC 1.12%
ROICexc 1.24%
ROICexgc 1.38%
OM 1.18%
PM (TTM) N/A
GM 22.9%
FCFM 1.43%
ROA(3y)-2.07%
ROA(5y)-1.58%
ROE(3y)-6%
ROE(5y)-4.53%
ROIC(3y)3.71%
ROIC(5y)3.71%
ROICexc(3y)4.12%
ROICexc(5y)4.09%
ROICexgc(3y)4.67%
ROICexgc(5y)4.68%
ROCE(3y)5.38%
ROCE(5y)5.38%
ROICexgc growth 3Y1.29%
ROICexgc growth 5Y11.97%
ROICexc growth 3Y1.47%
ROICexc growth 5Y13.29%
OM growth 3Y-3.24%
OM growth 5Y6.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y3.54%
F-Score4
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 17.13
Debt/EBITDA 2.69
Cap/Depr 128.33%
Cap/Sales 9.5%
Interest Coverage 0.72
Cash Conversion 127.39%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.6
Altman-Z 1.55
F-Score4
WACC6.42%
ROIC/WACC0.18
Cap/Depr(3y)84.44%
Cap/Depr(5y)74.59%
Cap/Sales(3y)7.35%
Cap/Sales(5y)6.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.86%
EPS Next Y369.8%
EPS Next 2Y176.58%
EPS Next 3Y119.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-9%
Revenue growth 3Y-3.01%
Revenue growth 5Y2.08%
Sales Q2Q%-8.42%
Revenue Next Year2.36%
Revenue Next 2Y3.53%
Revenue Next 3Y4.5%
Revenue Next 5Y4.28%
EBIT growth 1Y112.89%
EBIT growth 3Y-6.15%
EBIT growth 5Y9.17%
EBIT Next Year345.81%
EBIT Next 3Y83.87%
EBIT Next 5YN/A
FCF growth 1Y-38.41%
FCF growth 3Y34.76%
FCF growth 5Y-30.69%
OCF growth 1Y6.73%
OCF growth 3Y20.98%
OCF growth 5Y-3.81%

ELRINGKLINGER AG / ZIL2.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ELRINGKLINGER AG?

ChartMill assigns a fundamental rating of 3 / 10 to ZIL2.DE.


What is the valuation status for ZIL2 stock?

ChartMill assigns a valuation rating of 4 / 10 to ELRINGKLINGER AG (ZIL2.DE). This can be considered as Fairly Valued.


What is the profitability of ZIL2 stock?

ELRINGKLINGER AG (ZIL2.DE) has a profitability rating of 3 / 10.


What is the financial health of ELRINGKLINGER AG (ZIL2.DE) stock?

The financial health rating of ELRINGKLINGER AG (ZIL2.DE) is 2 / 10.